Screener / SEC EDGAR /CIK 0001758009 /10-K filed Mar 2, 2026, compared with Mar 20, 2025 /Numbers from the XBRL of the 10-Ks
Nasdaq Technology · Software

Quantum Computing Inc. QUBT

Compare with peers Embed
New in the 10-K 9 paragraphs with nothing like them in the 10-K filed Mar 20, 2025 New in the 10-Q 14 paragraphs not in the 10-Q filed Aug 10, 2026 10-Q against the 10-K 2 risk factor paragraphs and sentences added or reworded

New risk paragraphs, branching off last year

Each branch is a paragraph in Risk Factors with nothing like it in the 10-K filed Mar 20, 2025. A box jumps to the paragraph as filed, below.

9 new

Paragraphs with nothing like them in last year's 10-K

Quoted exactly

9 paragraphs in Risk Factors of the 10-K filed Mar 2, 2026 with nothing like them in the 10-K filed Mar 20, 2025. Quoted exactly. Paragraphs that were only edited are under 10-K change.

In order to grow our business, we may acquire additional assets or companies. For example, we acquired Luminar in February 2026. In connection with these acquisitions or any future acquisitions, there can be no assurance that we will be able to identify, acquire or obtain the required regulatory approvals, or profitably manage the additional businesses or successfully integrate any acquired businesses, products, or technologies without substantial expenses, delays or other operational, regulatory or financial problems. In addition, any acquired businesses, products or technologies may not achieve anticipated revenues and income growth.

Further, acquisitions may involve a number of additional risks, including diversion of management’s attention, failure to retain key personnel, or failure to attract the necessary talent to manage organizational growth. We may become responsible for unexpected liabilities that were not discovered or disclosed in the course of due diligence in connection with historical acquisitions and any future acquisitions. Additionally, acquisitions with international operations expose us to greater international business risks. If we do not realize the expected benefits or synergies of an acquisition, such as revenue gains or cost reductions, there could be a material adverse effect on our business, results of operations, and financial condition.

We may also seek to divest portions of our businesses which may no longer be aligned with our strategic initiatives and long-term objectives. Various factors could materially affect our ability to successfully do so, including the availability of buyers willing to purchase the assets on terms acceptable to us, difficulties in the separation of operations, the diversion of management’s attention from other business concerns, the disruption of our business, the potential loss of key employees, and the retention of uncertain contingent liabilities related to the divested business. We cannot assure that we will be successful in managing these or any other significant risks that we encounter in divesting a business or product line, and any divestiture we undertake could materially and adversely affect our business, financial condition, results of operations and cash flows.

Read in the 10-K

We have identified material weaknesses in our internal control over financial reporting and may identify additional material weaknesses in the future or otherwise fail to maintain an effective system of internal control, which may result in material misstatements of our financial statements or cause us to fail to meet our periodic reporting obligations.

We have identified material weaknesses in our internal controls over financial reporting as of December 31, 2024 and 2023. A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting such that there is a reasonable possibility that a material misstatement of our annual or interim financial statements will not be prevented or detected on a timely basis. Please see Item 9A. Controls and Procedures included elsewhere in this Annual Report for more information about identified material weaknesses.

We are in the process of designing and implementing measures to improve our internal controls over financial reporting to remediate the material weaknesses described in Item 9A. Controls and Procedures, primarily by implementing additional review procedures within our accounting and finance department, hiring additional personnel within the Company’s accounting and finance function, designing and implementing information technology and application controls in our financially significant systems, providing internal resources with enhanced access to accounting literature and research materials, engaging additional external accounting experts to supplement our internal resources and increasing communication with third-party professionals with whom we consult regarding the application of accounting standards on complex transactions and instruments.

While we are designing and implementing measures to remediate the material weaknesses, we cannot predict the success of such measures or the outcome of our assessment of these measures at this time. We can give no assurance that these measures will remediate the weaknesses in internal control or that additional material weaknesses or significant deficiencies in our internal controls over financial reporting will not be identified in the future. Our failure to implement and maintain effective internal controls over financial reporting could result in errors in our financial statements that may lead to a restatement of our financial statements or cause us to fail to meet our reporting obligations. Further, any failure to implement and maintain effective internal controls over financial reporting, information technology and management processes could adversely affect our financial results and the assessments by our independent registered public accounting firm and their attestation reports, if applicable. Additionally, Astra may not be able to complete our evaluation, testing and any required remediation in a timely fashion. Finally, our current controls and any new controls that we develop may become inadequate because of poor design and changes in our business, including increased complexity resulting from any international expansion.

To comply with the requirements of being a public company, we are undertaking various actions and expect to need to undertake additional actions, such as implementing new internal controls and procedures and hiring additional accounting or internal audit staff. Failure to comply with the Sarbanes-Oxley Act could potentially subject us to sanctions or investigations by the SEC, the Nasdaq Stock Market LLC (“Nasdaq”) or other regulatory authorities, which would require additional financial and management resources.

If we are unable to certify the effectiveness of our internal controls, or if our internal controls have material weaknesses, we may not detect errors in a timely manner, our financial statements could be misstated, we could be subject to regulatory scrutiny and a loss of confidence by stakeholders, which could harm our business, financial condition and results of operations and adversely affect the market price of our securities. We may also face litigation as a result of the material weaknesses in our internal control over financial reporting. Any such litigation, whether successful or not, could have a material adverse effect on our business, results of operations and financial condition.

Read in the 10-K

Paragraphs in the 10-Q filed Nov 9, 2026 that were not in the one before

New in the latest 10-Q

14 paragraphs in the 10-Q filed Nov 9, 2026 with nothing like them in the 10-Q filed Aug 10, 2026 (at least half the words must differ; new numbers alone do not count). Quoted exactly, grouped by the item heading above them. This is text that changed, not a judgement of how serious it is.

Financial statements and notes

semiconductor products, including lasers, photodetectors and avalanche diodes, as well as NHanced's engineering and advanced packaging services.

Read in the 10-Q

goodwill and intangible assets, deferred tax assets, equity-based transactions and liquidity assessment. Actual results may differ from these estimates.

Read in the 10-Q

Adjustments of $ 8 thousand for working capital were made to the preliminary purchase price during the three months ended September 30, 2026.

Read in the 10-Q

During the three months ended September 30, 2026, there was a $ 3.8 million change in purchase price primarily related to the valuation of contingent consideration. In addition, changes to the purchase price allocation was made as certain of the fair value amounts previously estimated were adjusted during the measurement period. These measurement period adjustments related to updated valuation reports and appraisals received from our external valuation specialists as well as changes in internal estimates. The changes in estimates recorded in the three months ended September 30, 2026 include a decrease in inventory of $ 3.5 million; a decrease in property and equipment of $ 7.6 million; an increase in intangibles of $ 35.9 million; and an increase in other current assets and liabilities, net, of $ 0.2 million. The change in purchase price and the measurement periods adjustments resulted in a decrease in goodwill of $ 21.1 million. These adjustments were not material to the consolidated statements of operations for the three and nine months ended September 30, 2026.

Read in the 10-Q

The Company’s strategy is focused on three complementary capabilities: quantum optics, integrated photonics, and advanced manufacturing. Quantum optics supports the development of quantum computing, sensing, and communications; integrated photonics supports the design and development of photonic circuits and components; and manufacturing operations provide fabrication, advanced packaging and related services for internal development and external customers. Together, these capabilities support the Company’s technology roadmap and commercial activities.

Read in the 10-Q
Show the other 9

During the first half of 2026, the Company completed the acquisitions of LSI, NuCrypt and NHanced, to expand its capabilities across quantum optics, integrated photonics and advanced photonics manufacturing. LSI added photonic semiconductor design, components, fabrication and packaging capabilities, in addition to commercial products and customer relationships. NuCrypt expanded the Company’s quantum communications portfolio, while NHanced added nanophotonics fabrication and advanced packaging capabilities. Together, these acquisitions broadened the Company’s commercial product and service offerings and manufacturing operations and provide additional capabilities to support its quantum photonics technology roadmap.

Read in the 10-Q

The expansion of our commercial operations and activity, including the recent LSI, NuCrypt and NHanced acquisitions, is an important factor affecting our financial performance. These acquisitions broadened our photonics products and services, manufacturing capabilities, and customer relationships. Our ability to retain and expand customer relationships, generate new business and increase utilization of our manufacturing capabilities will influence future revenue and profitability. The Company expects that continued improvements in commercial performance will influence revenue and profitability while supporting ongoing investments in its quantum technology roadmap.

Read in the 10-Q

Gross profit for the three months ended September 30, 2026, was $428 thousand compared to $126 thousand for the same period last year. Gross profit (loss) for the nine months ended September 30, 2026, was a loss of $1.5 million compared to a gross profit of $165 thousand for the same period last year.

Read in the 10-Q

Gross margins are influenced by production volumes and manufacturing utilization, particularly as the Company continues to integrate and scale its operations. Amortization of intangible assets of $2.7 million also served to depress gross margins. While the company generated positive gross profit in the third quarter of 2026, lower volumes and fixed costs from recent acquisitions contributed to a gross loss for the nine-month period. Increasing production volume, improving manufacturing utilization and driving operating efficiency are expected to be important factors affecting future gross margins.

Read in the 10-Q

The Company’s financial resources support its continued investment across three strategic priorities: expand its commercial photonics business, scale manufacturing capabilities and advance the quantum roadmap. These investments include research and development, product commercialization, manufacturing infrastructure and go-to-market activities. In addition, we expect to continue investing in our TFLN chip manufacturing capabilities, including our Foundry Services offering at our Arizona Chips Facility, potential facility expansion and the development of our quantum optics and integrated photonics technologies.

Read in the 10-Q

Additional debt or equity financing could dilute existing shareholders or introduce terms affecting their rights. In addition, debt financing may introduce covenants that restrict certain business activities. If sufficient capital is not available when needed, we may be required to delay, limit, or substantially reduce our product development, manufacturing expansion and go-to-market efforts. We believe, however, that existing cash, cash equivalents and investments, together with any cash generated from operations and the proceeds from any additional equity or debt issuances will be sufficient to meet the our anticipated working capital and capital expenditure needs for at least the next 12 months.

Read in the 10-Q

Controls and procedures

The Company has taken steps to strengthen its internal controls over financial reporting and continues to make progress in addressing previously identified material weaknesses.

Read in the 10-Q

Risk Factors

We do not believe we are an investment company under the Investment Company Act of 1940; however, if we were required to register as an investment company, our business could be materially and adversely affected.

Read in the 10-Q

We are primarily engaged, directly and through our wholly-owned subsidiaries, in the business of developing, manufacturing and selling quantum and photonic technologies, products and services, and we do not believe that we are an investment company under the Investment Company Act of 1940, as amended (the “Investment Company Act”). We hold a significant portion of our assets in cash, cash equivalents and short- and long-term investments pending their use in our operations. Whether a company is an investment company depends on the composition of its assets and income and on the nature of its business and activities, which may change over time, and there can be no assurance that the SEC or a court would agree with our position. Maintaining our position may require us to limit the types of investments we hold or the transactions we pursue. If we were required to register under the Investment Company Act, we would become subject to substantial regulation that is inconsistent with our business model, which could have a material adverse effect on our business, financial condition and results of operations.

Read in the 10-Q

The 10-Q's risk factors against the 10-K

Item 1A of the 10-Q filed Nov 9, 2026 against Item 1A of the 10-K filed Mar 2, 2026. A 10-Q repeats only the risks that changed, so a 10-K paragraph that is missing from it is not counted as removed. Added is a paragraph with nothing like it in the 10-K, Reworded a sentence that is in both with several words changed, Quiet changes a sentence in both where one to four words changed and one is a hedge or a modal (cut words struck through, new words highlighted). Text on the page, not a score; each links to the filing at sec.gov.

What the 10-Q itself says about its risk factors:Other than the additional risk factor set forth below, there were no material changes to the risk factors disclosed in Part I, Item 1A, Risk Factors of our Annual Report on the Form 10-K for the year ended December 31, 2025 as filed with the SEC on March 2, 2026, as updated by Part II, Item 1A, Risk Factors of our Quarterly Reports on Form 10-Q for the quarterly periods ended March 31, 2026 and June 30, 2026, as filed with the SEC on May 11, 2026 and August 10, 2026, respectively.

Read in the 10-Q
Added10-Q Nov 9, 2026 vs 10-K Mar 2, 2026
We do not believe we are an investment company under the Investment Company Act of 1940; however, if we were required to register as an investment company, our business could be materially and adversely affected.

Read it in the 10-Q at sec.gov

Added10-Q Nov 9, 2026 vs 10-K Mar 2, 2026
We are primarily engaged, directly and through our wholly-owned subsidiaries, in the business of developing, manufacturing and selling quantum and photonic technologies, products and services, and we do not believe that we are an investment company under the Investment Company Act of 1940, as amended (the “Investment Company Act”). We hold a significant portion of our assets in cash, cash equivalents and short- and long-term investments pending their use in our operations. Whether a company is an investment company depends on the composition of its assets and income and on the nature of its business and activities, which may change over time, and there can be no assurance that the SEC or a court would agree with our position. Maintaining our position may require us to limit the types of investments we hold or the transactions we pursue. If we were required to register under the Investment Company Act, we would become subject to substantial regulation that is inconsistent with our business model, which could have a material adverse effect on our business, financial condition and results of operations.

Read it in the 10-Q at sec.gov

Phrases used for the first time

Two-word phrases in Risk Factors of the 10-K filed Mar 2, 2026 that are in none of the 1 earlier 10-Ks stored, back to Mar 20, 2025

geopolitical tensions ×2export controls ×2foreign government ×2government policies ×2policies affecting ×2affecting cross-border ×2cross-border commerce ×2acquired luminar ×2wafer manufacturing ×2reporting obligations ×2item controls ×2implementing measures ×2hiring additional ×2internal resources ×2maintain effective ×2maintain form ×2
Where each one is used
  • geopolitical tensions: Our ability to scale is dependent also upon components that we must source from multiple countries, including China. Our supply chain could be adversely affected by geopolitical tensions, export controls, trade restrictions, tariffs or other changes in U.S. or foreign government policies affecting cross-border...
  • export controls: Our ability to scale is dependent also upon components that we must source from multiple countries, including China. Our supply chain could be adversely affected by geopolitical tensions, export controls, trade restrictions, tariffs or other changes in U.S. or foreign government policies affecting cross-border...
  • foreign government: Our ability to scale is dependent also upon components that we must source from multiple countries, including China. Our supply chain could be adversely affected by geopolitical tensions, export controls, trade restrictions, tariffs or other changes in U.S. or foreign government policies affecting cross-border...
  • government policies: Our ability to scale is dependent also upon components that we must source from multiple countries, including China. Our supply chain could be adversely affected by geopolitical tensions, export controls, trade restrictions, tariffs or other changes in U.S. or foreign government policies affecting cross-border...
  • policies affecting: Our ability to scale is dependent also upon components that we must source from multiple countries, including China. Our supply chain could be adversely affected by geopolitical tensions, export controls, trade restrictions, tariffs or other changes in U.S. or foreign government policies affecting cross-border...
  • affecting cross-border: Our ability to scale is dependent also upon components that we must source from multiple countries, including China. Our supply chain could be adversely affected by geopolitical tensions, export controls, trade restrictions, tariffs or other changes in U.S. or foreign government policies affecting cross-border...
  • cross-border commerce: Our ability to scale is dependent also upon components that we must source from multiple countries, including China. Our supply chain could be adversely affected by geopolitical tensions, export controls, trade restrictions, tariffs or other changes in U.S. or foreign government policies affecting cross-border...
  • acquired luminar: In order to grow our business, we may acquire additional assets or companies. For example, we acquired Luminar in February 2026. In connection with these acquisitions or any future acquisitions, there can be no assurance that we will be able to identify, acquire or obtain the required regulatory approvals, or...

The 10-K at sec.gov

Used at least twice, small words left out. Counted, not picked: a phrase can be new because the company renamed something.

What was taken out

7 paragraphs of last year's Risk Factors with nothing like them now. The longest are quoted.

Across all companies
Trading in our common stock has from time to time been and may continue to be subject to the SEC’s “penny stock” rules. The SEC has adopted regulations that generally define a penny stock to be any equity security that has a market price of less than $5.00 per share, subject to certain exceptions. These rules require that any broker-dealer that recommends our common stock to persons other than prior customers and accredited investors must, prior to the sale, make a special written suitability determination for the purchaser and receive the purchaser’s written agreement to execute the...
In the 10-K filed Mar 20, 2025
Subsequent to the issuance of our Annual Report on Form 10-K for the year ended December 31, 2023, and our subsequent retention of BPM LLP to replace BF Borgers CPA PC as our independent registered public accounting firm, management became aware of various adjustments to be recorded to our consolidated financial statements. On September 11, 2024, we filed Amendment 1 to our Annual Report on Form 10-K for the year ended December 31, 2023, restating our financial statements for the years ended December 31, 2023 and 2022 to correct errors primarily related to purchase accounting for the...
In the 10-K filed Mar 20, 2025
Effective internal control is necessary for us to provide reliable financial reports and prevent fraud. If we cannot provide reliable financial reports or prevent fraud, we may not be able to manage our business as effectively as we would if an effective control environment existed, and our business and reputation with investors may be harmed. As a result, our small size and any current internal control deficiencies may adversely affect our financial condition, results of operations and access to capital.
In the 10-K filed Mar 20, 2025
These restatements were necessitated in part by deficiencies in our internal control over financial reporting, which management concluded was not effective as of September 30, 2024. Material weaknesses in our controls, including those related to the timely detection and correction of financial reporting errors, coupled with the replacement of our independent auditor, resulted in delayed filings of our Quarterly Reports on Form 10-Q for the periods ended March 31, 2024, and June 30, 2024.
In the 10-K filed Mar 20, 2025

Sources

Item 1A of each 10-K and 10-Q on EDGAR, quoted exactly. Each paragraph links to the filing at sec.gov.

Also

10-K change: what was reworded or cut, section by section.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/QUBT/export.csv") into a cell.

Next:10-K change
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.